Horan Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53
Closed -$1.1K 468
2023
Q2
$1.1K Hold
53
﹤0.01% 619
2023
Q1
$1.24K Buy
53
+1
+2% +$27 ﹤0.01% 608
2022
Q4
$1.45K Buy
52
+29
+126% +$742 ﹤0.01% 584
2022
Q3
$1K Sell
23
-26
-53% -$785 ﹤0.01% 553
2022
Q2
$2K Sell
49
-142
-74% -$4.97K ﹤0.01% 561
2022
Q1
$7K Buy
191
+1
+0.5% +$34 ﹤0.01% 352
2021
Q4
$6K Buy
+190
New +$6.19K ﹤0.01% 372
2021
Q2
$6K Buy
+196
New +$6.45K ﹤0.01% 348

Other funds holding OGN

Horan Securities's OGN Position: Q3 2023 in Review

Horan Securities sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 53 shares — an estimated $1.1K sold.

Horan Securities first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $7K in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Horan Securities reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 53 Organon & Co shares in Q3 2023, an estimated $1.1K.
  • Horan Securities first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Horan Securities's Organon & Co position peaked at $7K in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.